SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment
Clinical trial NCT06480136 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06480136
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-15
- Primary completion
- 2027-06-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.